{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -1.9461466, "regularMarketPrice": 18.39, "exchange": "FRA", "shortName": "ROCKET PHARMAT. DL-,01", "longName": "Rocket Pharmaceuticals, Inc.", "messageBoardId": "finmb_427906624", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683892036, "regularMarketDayHigh": 18.39, "regularMarketDayRange": "18.3 - 18.39", "regularMarketDayLow": 18.3, "regularMarketVolume": 12, "regularMarketPreviousClose": 18.755, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 18.305, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 1, "fiftyTwoWeekLowChange": 10.754, "fiftyTwoWeekLowChangePercent": 1.4083289, "fiftyTwoWeekRange": "7.636 - 21.37", "fiftyTwoWeekHighChange": -2.9800014, "fiftyTwoWeekHighChangePercent": -0.13944788, "fiftyTwoWeekLow": 7.636, "fiftyTwoWeekHigh": 21.37, "earningsTimestamp": 1683230460, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.95, "epsForward": -2.56, "epsCurrentYear": -2.43, "priceEpsCurrentYear": -7.5679007, "sharesOutstanding": 80461296, "bookValue": 6.189, "fiftyDayAverage": 16.8481, "fiftyDayAverageChange": 1.5418987, "fiftyDayAverageChangePercent": 0.09151766, "twoHundredDayAverage": 17.07795, "twoHundredDayAverageChange": 1.3120499, "twoHundredDayAverageChangePercent": 0.07682713, "marketCap": 1510054400, "forwardPE": -7.1835938, "priceToBook": 2.9714007, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1426748400000, "priceHint": 2, "regularMarketChange": -0.36499977, "symbol": "9IP1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "9 Cedarbrook Drive", "city": "Cranbury", "state": "NJ", "zip": "08512", "country": "United States", "phone": "609 659 8001", "website": "https://rocketpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energ\u00e9ticas, Medioambientales y Tecnol\u00f3gicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.", "fullTimeEmployees": 240, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gaurav D. Shah M.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 1053223, "fmt": "1.05M", "longFmt": "1,053,223"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1905557, "fmt": "1.91M", "longFmt": "1,905,557"}}, {"maxAge": 1, "name": "Ms. Kinnari  Patel M.B.A., MBA, Pharm.D., PharmD", "age": 43, "title": "Pres & COO", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": {"raw": 849928, "fmt": "849.93k", "longFmt": "849,928"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John C. Militello CPA, CPA", "age": 49, "title": "VP, Sr. Controller, Treasurer, Principal Accounting Officer & Interim Principal Financial Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 501421, "fmt": "501.42k", "longFmt": "501,421"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3457, "fmt": "3.46k", "longFmt": "3,457"}}, {"maxAge": 1, "name": "Mr. Mayo  Pujols", "age": 53, "title": "Chief Technical Officer & Exec. VP", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 649711, "fmt": "649.71k", "longFmt": "649,711"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Raj  Prabhakar M.B.A.", "age": 48, "title": "Sr. VP & Chief Bus. Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 619127, "fmt": "619.13k", "longFmt": "619,127"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 55650, "fmt": "55.65k", "longFmt": "55,650"}}, {"maxAge": 1, "name": "Ms. Jessie  Yeung M.B.A.", "title": "VP of Investor Relations & Corp. Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Martin Louis Wilson J.D.", "age": 46, "title": "Gen. Counsel, Chief Compliance Officer & Sr. VP", "yearBorn": 1976, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Kevin  Giordano", "title": "Director of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Isabel  Carmona J.D.", "title": "Sr. VP & Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan  Schwartz M.D.", "age": 57, "title": "Chief Gene Therapy Officer & Sr. VP of Clinical Devel.", "yearBorn": 1965, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 10, "compensationRisk": 6, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}